相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dual-targeting Approach on Histamine H3 and Sigma-1 Receptor Ligands as Promising Pharmacological Tools in the Treatment of CNS-linked Disorders
Katarzyna Szczepanska et al.
CURRENT MEDICINAL CHEMISTRY (2021)
Structural modifications in the distal, regulatory region of histamine H3 receptor antagonists leading to the identification of a potent anti-obesity agent
Katarzyna Szczepanska et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
KD-64-A new selective A2Aadenosine receptor antagonist has anti-inflammatory activity but contrary to the non-selective antagonist-Caffeine does not reduce diet-induced obesity in mice
Magdalena Kotanska et al.
PLOS ONE (2020)
Evaluating the Impact of Different Hypercaloric Diets on Weight Gain, Insulin Resistance, Glucose Intolerance, and its Comorbidities in Rats
Bernardete F. Melo et al.
NUTRIENTS (2019)
Central Histamine, the H3-Receptor and Obesity Therapy
Nestor F. Diaz et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2019)
The 1,3,5-Triazine Derivatives as Innovative Chemical Family of 5-HT6 Serotonin Receptor Agents with Therapeutic Perspectives for Cognitive Impairment
Gniewomir Latacz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
KSK19-Novel histamine H3 receptor ligand reduces body weight in diet induced obese mice
Magdalena Kotanska et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Structural modifications and in vitro pharmacological evaluation of 4-pyridyl-piperazine derivatives as an active and selective histamine H3 receptor ligands
Katarzyna Szczepanska et al.
BIOORGANIC CHEMISTRY (2019)
Synthesis and biological activity of novel tert-butyl and tert-pentylphenoxyalkyl piperazine derivatives as histamine H3R ligands
Katarzyna Szczepanska et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Idalopirdine, a selective 5-HT6 receptor antagonist, reduces food intake and body weight in a model of excessive eating
Magdalena Kotanska et al.
METABOLIC BRAIN DISEASE (2018)
The histamine H-3 receptor inverse agonist pitolisant reduces body weight in obese mice
Magdalena Kotanska et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2018)
Optimization and preclinical evaluation of novel histamine H-3 receptor ligands: Acetyl and propionyl phenoxyalkyl piperazine derivatives
Katarzyna Szczepanska et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Computer-Aided Studies for Novel Arylhydantoin 1,3,5-Triazine Derivatives as 5-HT6 Serotonin Receptor Ligands with Antidepressive-Like, Anxiolytic and Antiobesity Action In Vivo
Rafal Kurczab et al.
MOLECULES (2018)
A behavioral and pharmacological characterization of palatable diet alternation in mice
Catherine F. Moore et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2017)
Metabolic and Cardiovascular Benefits and Risks of EMD386088-A 5-HT6 Receptor Partial Agonist and Dopamine Transporter Inhibitor
Magdalena Kotanska et al.
FRONTIERS IN NEUROSCIENCE (2017)
Idalopirdine - a small molecule antagonist of 5-HT6 with therapeutic potential against obesity
Magdalena Dudek et al.
METABOLIC BRAIN DISEASE (2015)
A Comparison of the Anorectic Effect and Safety of the Alpha2-Adrenoceptor Ligands Guanfacine and Yohimbine in Rats with Diet-Induced Obesity
Magdalena Dudek et al.
PLOS ONE (2015)
The expression and function of histamine H-3 receptors in pancreatic beta cells
T. Nakamura et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
The other side of the histamine H3 receptor
Bart A. Ellenbroek et al.
TRENDS IN NEUROSCIENCES (2014)
Role of leptin and adiponectin in insulin resistance
Amita Yadav et al.
CLINICA CHIMICA ACTA (2013)
Obesity pharmacotherapy: What is next?
Francheska Colon-Gonzalez et al.
MOLECULAR ASPECTS OF MEDICINE (2013)
Glucagon as a Critical Factor in the Pathology of Diabetes
Dale S. Edgerton et al.
DIABETES (2011)
Physiologic action of glucagon on liver glucose metabolism
C. J. Ramnanan et al.
DIABETES OBESITY & METABOLISM (2011)
The Histamine H-3 Receptor and Eating Behavior
Maria Beatrice Passani et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers
Paul J. Limburg et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Histamine H3 receptor antagonists:: Preclinical promise for treating obesity and cognitive disorders
TA Esbenshade et al.
MOLECULAR INTERVENTIONS (2006)
Histamine H3 receptor antagonists reach out for the clinic
S Celanire et al.
DRUG DISCOVERY TODAY (2005)
How palatable food disrupts appetite regulation
C Erlanson-Albertsson
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2005)
Influence of exogenous insulin on C-peptide levels in subjects with type 2 diabetes
M Albareda et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2005)
Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle
JK Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Study of the alteration of gene expression in adipose tissue of diet-induced obese mice by microarray and reverse transcription-polymerase chain reaction analyses
RC Moraes et al.
ENDOCRINOLOGY (2003)
分享论文
